copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Prostate-Specific Antigen (PSA) Test - NCI - National Cancer Institute Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland Both prostate cancer and several benign conditions (particularly benign prostatic hyperplasia, or BPH, and prostatitis) can cause PSA levels in the blood to rise The PSA test measures the level of PSA in the blood
Prostate Cancer Screening - NCI - National Cancer Institute A PSA test or a DRE may be able to detect prostate cancer at an early stage, but it is not clear whether early detection and treatment decrease the risk of dying from prostate cancer Studies are being done to find ways to make PSA testing more accurate for early cancer detection
Understanding Prostate Changes and Conditions - National Cancer Institute Learn more about the prostate-specific antigen (PSA) test Symptoms of prostate cancer Early-stage prostate cancer does not usually cause symptoms However, locally advanced prostate cancer may cause urinary symptoms including blood in the urine or semen or pain in the back, hips, or pelvis that doesn’t go away
Prostate Cancer Screening (PDQ®) - NCI - National Cancer Institute The evidence is insufficient to determine whether screening for prostate cancer with prostate-specific antigen (PSA) or digital rectal exam (DRE) reduces mortality from prostate cancer Screening tests can detect prostate cancer at an early stage, but it is not clear whether earlier detection and consequent earlier treatment leads to any change
Prueba del antígeno prostático específico (PSA) El antígeno prostático específico o PSA es una proteína que producen tanto las células normales como las células malignas (cancerosas) de la próstata Tanto el cáncer de próstata como varias afecciones benignas (en particular la hiperplasia prostática benigna, o HPB, y la prostatitis) hacen que aumenten las concentraciones del PSA en la sangre
Prostate Cancer Screening | Cancer Trends Progress Report Prostate-specific antigen, or PSA, is a protein produced by normal, as well as malignant, cells of the prostate gland The PSA test measures the level of PSA in a man’s blood For this test, a blood sample is sent to a laboratory for analysis In 2012 the U S Preventive Services Task Force (USPSTF) recommended against prostate cancer screening
The PSA Test for Prostate Cancer: Is it Right for ME? Designed to increase knowledge and patient participation in the decision-making process for prostate cancer screening, this intervention consists of a pamphlet mailed to patients prior to their provider appointment that presents balanced information about the potential risks and benefits of screening, the accuracy of the prostate-specific antigen (PSA) test, and the efficacy of prostate cancer
An Improved Prostate Cancer Biomarker Test May Help Men Avoid . . . The most widely used prostate cancer screening methods are a PSA blood test and digital rectal exam (DRE), but these methods are imprecise Though blood PSA levels will be elevated when cancer is present, PSA can also be high with non-cancerous conditions of the prostate, with low-grade, slow growing cancers, or if someone had a recent prior biopsy
Definition of PSA test - NCI Dictionary of Cancer Terms A laboratory test that measures the amount of prostate-specific antigen (PSA) found in the blood PSA is a protein made by the prostate gland The amount of PSA may be higher in men who have prostate cancer, benign prostatic hyperplasia (BPH), or infection or inflammation of the prostate Also called prostate-specific antigen test
Prostate Cancer Treatment - NCI - National Cancer Institute The results of the tests used to diagnose prostate cancer are often also used to stage the disease (See the General Information section ) In prostate cancer, staging tests may not be done unless the patient has symptoms or signs that the cancer has spread, such as bone pain, a high PSA level, or a high Gleason score